Growth Stocks
Although growth stock picks can be highly volatile, they can make good long-term investments. They may be well-known stars or quiet gems, but they do share one common attribute—they are growing at a higher-than-average rate within their industry, or within the market as a whole, and could keep growing for years or decades.
And keep in mind that we focus on growth stocks, which have a good long-term history and favourable prospects. We downplay momentum stocks that tend to attract many investors simply because they are moving faster than the market averages, but are liable to fall sharply when their momentum fades.
There’s room for growth stock investing in your portfolio, but make sure you follow our TSI Network three-part Successful Investor strategy for your overall portfolio:
- Invest mainly in well-established companies;
- Spread your money out across most if not all of the five main economic sectors (Manufacturing & Industry; Resources & Commodities; Consumer; Finance; Utilities);
- Downplay or avoid stocks in the broker/media limelight.
Make better stock picks when you read this FREE Special Report, Canadian Growth Stocks: WestJet Stock, RioCan Stock and More.
Read More
Close
ALIMENTATION COUCHETARD $44.55 (Toronto symbol ATD.B; TSINetwork Rating: Extra Risk) (1-800-361-2612; www.couchetard. com; Shares outstanding: 565.8 million; Market cap: $25.4 billion; Dividend yield: 0.4%) is buying The Pantry (symbol PTRY on Nasdaq), which operates more than 1,500 convenience stores in 13 southern U.S. states.
Couche-Tard will pay $1.7 billion—$ 860 million in cash and the assumption of $840 million of debt. This is its biggest purchase since it paid $2.7 billion U.S. for Norway’s Statoil Fuel & Retail gas station chain in June 2012.
Founded in 1967, The Pantry mainly grew through acquisitions beginning in the late 1980s. Like Couche-Tard, it focuses on selling higher-margin fresh food. It sells its own private-label bottled water and is the fifth-largest location for Subway restaurants.
...
Couche-Tard will pay $1.7 billion—$ 860 million in cash and the assumption of $840 million of debt. This is its biggest purchase since it paid $2.7 billion U.S. for Norway’s Statoil Fuel & Retail gas station chain in June 2012.
Founded in 1967, The Pantry mainly grew through acquisitions beginning in the late 1980s. Like Couche-Tard, it focuses on selling higher-margin fresh food. It sells its own private-label bottled water and is the fifth-largest location for Subway restaurants.
...
DOREL INDUSTRIES $39.05 (Toronto symbol DII.B; TSINetwork Rating: Extra Risk) (514-731-0000; www.dorel.com; Shares outstanding: 32.3 million; Market cap: $1.3 billion; Dividend yield: 3.5%) makes a range of items, including ready-to-assemble home and office furniture; juvenile products, such as car seats, strollers, high chairs, toddler beds and cribs; and recreational goods, mainly bicycles.
Dorel has grown quickly over the last 10 years, with revenue doubling from $1.2 billion in 2003 to $2.4 billion in 2013 (all figures except share price and market cap in U.S. dollars). This period included two big acquisitions: France’s Ampa Group for $240 million in 2003 and Dorel’s 2004 purchase of Pacific Cycle for $310 million.
In late 2013, Dorel acquired 70% of money-losing Caloi, a major Brazilian bike maker, for $73.0 million. It has now integrated Caloi’s production from its big plant in Manaus, Brazil into its distribution and sales network to the point that it’s now adding to Dorel’s profits.
...
Dorel has grown quickly over the last 10 years, with revenue doubling from $1.2 billion in 2003 to $2.4 billion in 2013 (all figures except share price and market cap in U.S. dollars). This period included two big acquisitions: France’s Ampa Group for $240 million in 2003 and Dorel’s 2004 purchase of Pacific Cycle for $310 million.
In late 2013, Dorel acquired 70% of money-losing Caloi, a major Brazilian bike maker, for $73.0 million. It has now integrated Caloi’s production from its big plant in Manaus, Brazil into its distribution and sales network to the point that it’s now adding to Dorel’s profits.
...
Every Wednesday, we publish our “Investor Toolkit” series on TSI Network. Whether you’re a new or experienced investor, these weekly updates are designed to give you specific investment advice. Each Investor Toolkit update gives you a fundamental piece of investing strategy, and shows you how you can put it into practice right away.
Today’s tip: “To get the maximum reward from rising stocks, it’s essential to pick stocks with clear growth prospects and not simply momentum stocks with uncertain futures.”
By definition, growth stocks are companies that have above-average growth prospects. They are firms whose earnings growth has been above the market average, and is likely to remain above average. It is often the case that they pay small dividends or none at all. Instead, they re-invest their cash flow in the business, to promote their growth.
...
Today’s tip: “To get the maximum reward from rising stocks, it’s essential to pick stocks with clear growth prospects and not simply momentum stocks with uncertain futures.”
By definition, growth stocks are companies that have above-average growth prospects. They are firms whose earnings growth has been above the market average, and is likely to remain above average. It is often the case that they pay small dividends or none at all. Instead, they re-invest their cash flow in the business, to promote their growth.
...
BAXTER INTERNATIONAL INC. $67 (New York symbol BAX; Conservative Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 542.0 million; Market cap: $36.3 billion; Price-to-sales ratio: 2.5; Dividend yield: 2.9%; TSINetwork Rating: Average; www.baxter.com) continues to expand overseas, which helps cut its exposure to the 2.3% excise tax it must pay on sales of medical devices as part of the Affordable Care Act (or Obamacare). In 2012, overseas markets supplied 58% of Baxter’s revenue.
The company recently completed its $3.7-billion purchase of Gambro AB, a Swedish dialysis-product maker. Gambro looks like a nice fit with Baxter’s intravenous pumps and other medical equipment. This division supplies 55% of its total revenue. The remaining 45% comes from its BioScience division, which produces vaccines and drugs.
In the three months ended September 30, 2013, Baxter’s revenue rose 8.5%, to $3.8 billion from $3.5 billion a year earlier. Gambro supplied $100 million of that total, which helped push up the medical products division’s sales by 10.2%. BioScience revenue rose 6.4% on strong demand for the division’s Advate hemophilia drug.
...
The company recently completed its $3.7-billion purchase of Gambro AB, a Swedish dialysis-product maker. Gambro looks like a nice fit with Baxter’s intravenous pumps and other medical equipment. This division supplies 55% of its total revenue. The remaining 45% comes from its BioScience division, which produces vaccines and drugs.
In the three months ended September 30, 2013, Baxter’s revenue rose 8.5%, to $3.8 billion from $3.5 billion a year earlier. Gambro supplied $100 million of that total, which helped push up the medical products division’s sales by 10.2%. BioScience revenue rose 6.4% on strong demand for the division’s Advate hemophilia drug.
...
MTS SYSTEMS CORP. $68 (Nasdaq symbol MTSC; Aggressive Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 15.4 million; Market cap: $1.0 billion; Price-to-sales ratio: 1.8; Dividend yield: 1.8%; TSINetwork Rating: Average; www.mts.com) makes equipment and software that manufacturers use to test the behaviour of materials, machines and structures. This helps its customers reduce errors and costs. Like 3M (see page 1), MTS is also spending more to develop new products.
In the fiscal year ended September 28, 2013, MTS’s revenue rose 5.0%, to $569.4 million from $542.3 million a year earlier. Earnings fell 5.4%, to $3.49 a share from $3.69, partly due to a 4.2% jump in research spending. MTS now devotes around 4% of its revenue to developing new products.
The company expects its fiscal 2014 earnings to improve to $3.55 to $3.70 a share. The stock trades at a reasonable 18.8 times the midpoint of that range.
...
In the fiscal year ended September 28, 2013, MTS’s revenue rose 5.0%, to $569.4 million from $542.3 million a year earlier. Earnings fell 5.4%, to $3.49 a share from $3.69, partly due to a 4.2% jump in research spending. MTS now devotes around 4% of its revenue to developing new products.
The company expects its fiscal 2014 earnings to improve to $3.55 to $3.70 a share. The stock trades at a reasonable 18.8 times the midpoint of that range.
...
ENCANA CORP. $18 (Toronto symbol ECA; Conservative Growth Portfolio, Resources sector; Shares outstanding: 740.1 million; Market cap: $13.3 billion; Price-to-sales ratio: 2.2; Dividend yield: 1.6%; TSINetwork Rating: Average; www.encana.com) plans to spend $2.4 billion to $2.5 billion on its properties in 2014. That’s down from the $2.8 billion it will likely spend in 2013.
Encana will devote 75% of its 2014 spending to five properties: Montney (B.C.), Duvernay (Alberta), DJ Basin (Colorado), San Juan Basin (New Mexico) and the Tuscaloosa Marine Shale (Louisiana).
These fields produce significant amounts of oil and natural gas liquids (NGLs), such as butane and propane. The company expects oil and NGLs to supply 75% of its cash flow by 2017, up from about 35% today.
...
Encana will devote 75% of its 2014 spending to five properties: Montney (B.C.), Duvernay (Alberta), DJ Basin (Colorado), San Juan Basin (New Mexico) and the Tuscaloosa Marine Shale (Louisiana).
These fields produce significant amounts of oil and natural gas liquids (NGLs), such as butane and propane. The company expects oil and NGLs to supply 75% of its cash flow by 2017, up from about 35% today.
...
C.R. BARD INC. $166 (New York symbol BCR; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 74.9 million; Market cap: $12.4 billion; Price-to-sales ratio: 3.9; Dividend yield: 0.5%; TSINetwork Rating: Above Average; www. crbard.com) makes over 15,000 medical devices in four main areas: oncology products that detect and treat various types of cancer (28% of 2013 sales); vascular products, like stents and catheters (27%); urology goods, such as drainage and incontinence devices (26%); and surgical tools (16%). Other medical products supply the remaining 3%.
The company’s products are typically only used once, so customers must continually buy new ones.
Acquisition targets fit well
...
The company’s products are typically only used once, so customers must continually buy new ones.
Acquisition targets fit well
...
RESTAURANT BRANDS INTERNATIONAL INC. $35 (New York symbol QSR; Aggressive Growth Portfolio, Consumer sector; Shares outstanding: 483.3 million; Market cap: $16.9 billion; Priceto- sales ratio: 0.7; Dividend yield: n.a.; TSINetwork Rating: Average; www.rbi.com) is the new company formed by the merger of Tim Hortons Inc. (old symbol THI) and Burger King Worldwide (old symbol BKW).
Restaurant Brands is the world’s third-largest fast-food chain, after McDonald’s and Yum Brands, with 14,000 Burger King restaurants and 4,590 Tim Hortons outlets in 100 countries. In all, these locations have annual sales of over $23 billion.
Roughly 72% of Tim Hortons shareholders opted to receive 3.0879 shares of the new company for each Tim Hortons share they held. A further 26% chose the default option of $65.50 (Canadian) in cash plus 0.8025 of a Restaurant Brands share, while 2% picked the all-cash option of $88.50 (Canadian) a share.
...
Restaurant Brands is the world’s third-largest fast-food chain, after McDonald’s and Yum Brands, with 14,000 Burger King restaurants and 4,590 Tim Hortons outlets in 100 countries. In all, these locations have annual sales of over $23 billion.
Roughly 72% of Tim Hortons shareholders opted to receive 3.0879 shares of the new company for each Tim Hortons share they held. A further 26% chose the default option of $65.50 (Canadian) in cash plus 0.8025 of a Restaurant Brands share, while 2% picked the all-cash option of $88.50 (Canadian) a share.
...
FRONTIER COMMUNICATIONS CORP. $6.36 (Nasdaq symbol FTR; Income Portfolio, Utilities sector; Shares outstanding: 1.0 billion; Market cap: $6.4 billion; Price-to-sales ratio: 1.4; Dividend yield: 6.6%; TSINetwork Rating: Average; www. frontier.com) recently completed its $2.0-billion purchase of AT&T’s traditional phone business in Connecticut. It now has 3.0 million customers in 28 states.
By combining these operations with its existing systems, Frontier has already cut its annual costs by $150 million. That should rise to $200 million a year by the end of 2017.
Thanks to these expected savings, Frontier has increased its quarterly dividend by 5.0%, to $0.105 a share from $0.10. The new annual rate of $0.42 yields 6.6%.
...
By combining these operations with its existing systems, Frontier has already cut its annual costs by $150 million. That should rise to $200 million a year by the end of 2017.
Thanks to these expected savings, Frontier has increased its quarterly dividend by 5.0%, to $0.105 a share from $0.10. The new annual rate of $0.42 yields 6.6%.
...
CONAGRA FOODS INC. $37 (New York symbol CAG; Income Portfolio, Consumer sector; Shares outstanding: 424.5 million; Market cap: $15.7 billion; Price-to-sales ratio: 0.9; Dividend yield: 2.7%; TSINetwork Rating: Above Average; www.conagrafoods .com) owns 50% of a plant in the Netherlands that makes frozen potato products; Holland-based Meijer Frozen Food owns the other 50%.
The partners now plan to increase this facility’s capacity by mid-2016. That will help them meet fast-food chains’ rising demand for french fries.
The joint venture has enough cash flow to cover the expansion’s $150-million cost, so ConAgra won’t have to commit any additional funds.
...
The partners now plan to increase this facility’s capacity by mid-2016. That will help them meet fast-food chains’ rising demand for french fries.
The joint venture has enough cash flow to cover the expansion’s $150-million cost, so ConAgra won’t have to commit any additional funds.
...